Quest Diagnostics
DGX
#1143
Rank
โ‚น1.763 T
Marketcap
โ‚น15,768
Share price
0.48%
Change (1 day)
22.38%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): โ‚น747.04

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น774.41. In 2024 the company made an earnings per share (EPS) of โ‚น697.33 an increase over its 2023 EPS that were of โ‚น680.30.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น747.047.13%
2024โ‚น697.332.5%
2023โ‚น680.30-5.83%
2022โ‚น722.43-49.21%
2021โ‚น1,42249.72%
2020โ‚น950.0966.67%
2019โ‚น570.0518%
2018โ‚น483.11-4.26%
2017โ‚น504.6223.19%
2016โ‚น409.61-7.11%
2015โ‚น440.9828.46%
2014โ‚น343.29-31.61%
2013โ‚น501.9360.46%
2012โ‚น312.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น918.72 18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น63.80-108.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น78.88-110.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น18.82-102.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น167.49-78.37%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands